Delivery Order SPE2DB20D1100-SPE2DB24FA0T9
- Not listed
- This federal contract award, valued at $73,503.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award covers the delivery of Jardiance 10 mg tablets over a period ending on October 25, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for...
- This federal contract award, valued at $41,300.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Jardiance 25 mg tablets over the period ending on February 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
- This contract award, valued at $5,665.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 90 tablets of the medication Jardiance 10 mg. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $7,641.69, is for the delivery of Jardiance 25 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is a delivery order worth $4,951.05 for the supply of the medication Jardiance 10 mg tablets. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of May 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,863.08 and is a Firm Fixed Price Delivery Order. It covers the supply of Jardiance 10 mg tablets to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under contract SPE2DX15D2205 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $57,280.95, is for the delivery of Jardiance 25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. The IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Jardiance 25 mg tablets. The $3,617.28 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Jardiance 25 mg Tablets in quantities of 90. The award, valued at $87,987.24, was made on June 15, 2022, with a completion date of June 16, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, with a ceiling value of $4,574.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4559491271 Jardiance 10 mg tablets. The award, which has no set-aside designation, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA0T9Delivery Order
This federal contract award, valued at $64,801.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of Jardiance 10 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. This specific delivery order has a firm fixed price and an ultimate completion date of February 6, 2024. The contract was awarded on an unrestricted basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $64.8k | 2/5/24 |